RADIOTHERAPY FOR ISOLATED SERUM PROSTATE SPECIFIC ANTIGEN ELEVATION AFTER PROSTATECTOMY FOR PROSTATE CANCER-Reference-Cited by-同舟云学术

RADIOTHERAPY FOR ISOLATED SERUM PROSTATE SPECIFIC ANTIGEN ELEVATION AFTER PROSTATECTOMY FOR PROSTATE CANCER

Published:2000-03 Issue:3 Volume:163 Page:845-850
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

PISANSKY THOMAS M.¹,KOZELSKY TIMOTHY F.¹,MYERS ROBERT P.¹,HILLMAN DAVID W.¹,BLUTE MICHAEL L.¹,BUSKIRK STEVEN J.¹,CHEVILLE JOHN C.¹,FERRIGNI ROBERT G.¹,SCHILD STEVEN E.¹

Affiliation:

1. From the Division of Radiation Oncology, Departments of Urology, and Laboratory Medicine and Pathology, and Cancer Center Statistical Unit, Mayo Clinic, Rochester, Minnesota, Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, and Departments of Urology and Radiation Oncology, Mayo Clinic, Scottsdale, Arizona

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference24 articles.

1. National patterns of prostate cancer treatment by radical prostatectomy: results of a survey by the American College of Surgeons Committee on Cancer;Murphy;J Urol,1994

2. Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment;McCarthy;J Urol,1994

3. Effect of radiation therapy after radical prostatectomy on serum prostate-specific antigen measured by an ultrasensitive assay;Haab;Urology,1995

4. The efficacy of post-prostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen;Wu;Int J Radiat Oncol Biol Phys,1995

5. Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy;Coetzee;Urology,1996

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial;European Urology Oncology;2024-05

2. Disparities in the Delivery of Prostate Cancer Survivorship Care in the USA: A Claims-based Analysis of Urinary Adverse Events and Erectile Dysfunction Among Prostate Cancer Survivors;European Urology Open Science;2024-04

3. Outcomes of salvage high dose-rate brachytherapy with or without pelvic external beam radiotherapy in patients with palpable local recurrence of prostate cancer after radical prostatectomy;Brachytherapy;2023-05

4. How can we best manage biochemical failure after radical prostatectomy?;Investigative and Clinical Urology;2022

5. Robotic Approach for Rectourethral Fistula;Urinary Fistula;2022